Cargando…
Differential Diagnosis of Fungal Pneumonias vs. Tuberculosis in AIDS Patients by Using Two New Molecular Methods
Opportunistic fungal pneumonias (OFP) are the main cause of death in AIDS patients worldwide. Diagnosis of these infections is often late as tuberculosis (TB) is frequently the first suspicion. In addition, diagnostic tools have limitations and are unavailable in disadvantaged regions. To perform th...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145742/ https://www.ncbi.nlm.nih.gov/pubmed/33925404 http://dx.doi.org/10.3390/jof7050336 |
_version_ | 1783697245248421888 |
---|---|
author | Bernal-Martínez, Leticia Herrera, Laura Valero, Clara de la Cruz, Paula Ghimpu, Larisa Mesa-Arango, Ana C. Santoni, Gabriela Goterris, Lidia Millán, Rosario Buitrago, María José |
author_facet | Bernal-Martínez, Leticia Herrera, Laura Valero, Clara de la Cruz, Paula Ghimpu, Larisa Mesa-Arango, Ana C. Santoni, Gabriela Goterris, Lidia Millán, Rosario Buitrago, María José |
author_sort | Bernal-Martínez, Leticia |
collection | PubMed |
description | Opportunistic fungal pneumonias (OFP) are the main cause of death in AIDS patients worldwide. Diagnosis of these infections is often late as tuberculosis (TB) is frequently the first suspicion. In addition, diagnostic tools have limitations and are unavailable in disadvantaged regions. To perform the differential diagnosis of the main fungi causing OFP in AIDS patients (Histoplasma capsulatum, Cryptococcus neoformans/C. gattii and Pneumocystis jirovecii) vs. the Mycobacterium tuberculosis complex (MTBC), two new assays were developed: (i) a multiplex real-time PCR (MRT-PCR) and (ii) a simple and cost-effective method based on real-time PCR and the analysis of melting curves after amplification (MC-PCR). Both of the techniques were optimized and standardized “in vitro”, showing a suitable reproducibility (CV ranged between 1.84 and 3.81% and 1.41 and 4.83%, respectively), a 100% specificity and detection limits between 20 and 2 fg of genomic DNA per 20 µL of reaction. A validation study was performed by retrospectively using 42 clinical samples from 37 patients with proven fungal infection or TB, and 33 controls. The overall sensitivity for the MRT-PCR assay and the MC-PCR assay was 88% and 90.4%, respectively. Both techniques were fast, sensitive and reproducible, allowing for the detection of these pathogens and the performance of a differential diagnosis. |
format | Online Article Text |
id | pubmed-8145742 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81457422021-05-26 Differential Diagnosis of Fungal Pneumonias vs. Tuberculosis in AIDS Patients by Using Two New Molecular Methods Bernal-Martínez, Leticia Herrera, Laura Valero, Clara de la Cruz, Paula Ghimpu, Larisa Mesa-Arango, Ana C. Santoni, Gabriela Goterris, Lidia Millán, Rosario Buitrago, María José J Fungi (Basel) Article Opportunistic fungal pneumonias (OFP) are the main cause of death in AIDS patients worldwide. Diagnosis of these infections is often late as tuberculosis (TB) is frequently the first suspicion. In addition, diagnostic tools have limitations and are unavailable in disadvantaged regions. To perform the differential diagnosis of the main fungi causing OFP in AIDS patients (Histoplasma capsulatum, Cryptococcus neoformans/C. gattii and Pneumocystis jirovecii) vs. the Mycobacterium tuberculosis complex (MTBC), two new assays were developed: (i) a multiplex real-time PCR (MRT-PCR) and (ii) a simple and cost-effective method based on real-time PCR and the analysis of melting curves after amplification (MC-PCR). Both of the techniques were optimized and standardized “in vitro”, showing a suitable reproducibility (CV ranged between 1.84 and 3.81% and 1.41 and 4.83%, respectively), a 100% specificity and detection limits between 20 and 2 fg of genomic DNA per 20 µL of reaction. A validation study was performed by retrospectively using 42 clinical samples from 37 patients with proven fungal infection or TB, and 33 controls. The overall sensitivity for the MRT-PCR assay and the MC-PCR assay was 88% and 90.4%, respectively. Both techniques were fast, sensitive and reproducible, allowing for the detection of these pathogens and the performance of a differential diagnosis. MDPI 2021-04-27 /pmc/articles/PMC8145742/ /pubmed/33925404 http://dx.doi.org/10.3390/jof7050336 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Bernal-Martínez, Leticia Herrera, Laura Valero, Clara de la Cruz, Paula Ghimpu, Larisa Mesa-Arango, Ana C. Santoni, Gabriela Goterris, Lidia Millán, Rosario Buitrago, María José Differential Diagnosis of Fungal Pneumonias vs. Tuberculosis in AIDS Patients by Using Two New Molecular Methods |
title | Differential Diagnosis of Fungal Pneumonias vs. Tuberculosis in AIDS Patients by Using Two New Molecular Methods |
title_full | Differential Diagnosis of Fungal Pneumonias vs. Tuberculosis in AIDS Patients by Using Two New Molecular Methods |
title_fullStr | Differential Diagnosis of Fungal Pneumonias vs. Tuberculosis in AIDS Patients by Using Two New Molecular Methods |
title_full_unstemmed | Differential Diagnosis of Fungal Pneumonias vs. Tuberculosis in AIDS Patients by Using Two New Molecular Methods |
title_short | Differential Diagnosis of Fungal Pneumonias vs. Tuberculosis in AIDS Patients by Using Two New Molecular Methods |
title_sort | differential diagnosis of fungal pneumonias vs. tuberculosis in aids patients by using two new molecular methods |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145742/ https://www.ncbi.nlm.nih.gov/pubmed/33925404 http://dx.doi.org/10.3390/jof7050336 |
work_keys_str_mv | AT bernalmartinezleticia differentialdiagnosisoffungalpneumoniasvstuberculosisinaidspatientsbyusingtwonewmolecularmethods AT herreralaura differentialdiagnosisoffungalpneumoniasvstuberculosisinaidspatientsbyusingtwonewmolecularmethods AT valeroclara differentialdiagnosisoffungalpneumoniasvstuberculosisinaidspatientsbyusingtwonewmolecularmethods AT delacruzpaula differentialdiagnosisoffungalpneumoniasvstuberculosisinaidspatientsbyusingtwonewmolecularmethods AT ghimpularisa differentialdiagnosisoffungalpneumoniasvstuberculosisinaidspatientsbyusingtwonewmolecularmethods AT mesaarangoanac differentialdiagnosisoffungalpneumoniasvstuberculosisinaidspatientsbyusingtwonewmolecularmethods AT santonigabriela differentialdiagnosisoffungalpneumoniasvstuberculosisinaidspatientsbyusingtwonewmolecularmethods AT goterrislidia differentialdiagnosisoffungalpneumoniasvstuberculosisinaidspatientsbyusingtwonewmolecularmethods AT millanrosario differentialdiagnosisoffungalpneumoniasvstuberculosisinaidspatientsbyusingtwonewmolecularmethods AT buitragomariajose differentialdiagnosisoffungalpneumoniasvstuberculosisinaidspatientsbyusingtwonewmolecularmethods |